A single-center experience in the management of Altemeier-Klatskin tumors
- PMID: 18193119
A single-center experience in the management of Altemeier-Klatskin tumors
Abstract
Aim: of this study is to present our experience in the management of patients with Altemeier-Klatskin tumor, with particular focus on the risk factors that influence survival after tumor resection.
Methods: Over a 15-year period, 37 patients with hilar cholangiocarcinoma were managed in our Department. The mean age of the patients was 62.5 years. Twenty-one patients were treated by palliative measures while sixteen patients had resection of the tumor and 11 of these had negative histological margins. An associated major hepatectomy was performed in six. In parallel, certain risk factors that could influence survival were analyzed.
Results: The resectability rate was 43.2%. The 30-day mortality rate was 7.4% and postoperative morbidity was 37.5%. The sites of the resected tumors were Bismuth-Corlette type I lesions in 3 patients, type II in 6, type IIIa in 2, and type IIIb in 5. The median survival of patients undergoing resection was significantly higher than of patients not undergoing resection (p<0.001). Furthermore, patients with R0 resection and histological clear margins experienced significantly superior survival than patients with R1 resection and positive margins (p=0.001, and p<0.001 respectively). Resections resulting in cancer-positive margins did not portend a survival benefit.
Conclusion: Negative surgical margins, tumor differentiation and infiltrating macroscopic appearance, were statistically significant prognostic factors. Our findings emphasize that complete resection of the tumor with negative histological margins offers the best possibility of long-term survival, and that the addition of hepatectomy to biliary resection results in a greater number of patients with margin negative resections.
Similar articles
-
Diagnostic and surgical features of Klatskin tumors.Chir Ital. 1999 Jan-Feb;51(1):1-7. Chir Ital. 1999. PMID: 10514910
-
In-continuity hepatic resection for advanced hilar cholangiocarcinoma.Am J Surg. 2004 Nov;188(5):584-8. doi: 10.1016/j.amjsurg.2004.07.035. Am J Surg. 2004. PMID: 15546575
-
Novel prognostic scoring system after surgery for Klatskin tumor.Am Surg. 2013 Jan;79(1):90-5. Am Surg. 2013. PMID: 23317618 Clinical Trial.
-
Current status of surgery for Klatskin tumors.Curr Opin Gen Surg. 1994:161-7. Curr Opin Gen Surg. 1994. PMID: 7583956 Review.
-
Hilar cholangiocarcinoma: current management.Ann Surg. 2009 Aug;250(2):210-8. doi: 10.1097/SLA.0b013e3181afe0ab. Ann Surg. 2009. PMID: 19638920 Review.
Cited by
-
Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.Pathol Oncol Res. 2013 Oct;19(4):815-20. doi: 10.1007/s12253-013-9649-6. Epub 2013 Jul 14. Pathol Oncol Res. 2013. PMID: 23852458
-
Klatskin Tumor: A Survival Analysis According to Tumor Characteristics and Inflammatory Ratios.Medicina (Kaunas). 2022 Dec 5;58(12):1788. doi: 10.3390/medicina58121788. Medicina (Kaunas). 2022. PMID: 36556990 Free PMC article.
-
Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinoma.World J Gastroenterol. 2009 Apr 21;15(15):1892-6. doi: 10.3748/wjg.15.1892. World J Gastroenterol. 2009. PMID: 19370789 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical